IRD

Opus Genetics
IRD

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $14.5M invested in Opus Genetics in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$322K
2
+$127K
3
+$101K
4
Morgan Stanley
Morgan Stanley
New York
+$4.76K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.62K

Top Sellers

1
-$55K
2
-$48K
3
-$30.2K
4
BlackRock
BlackRock
New York
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$13.4M
2
$479K
3
$322K
4
$127K
5
$93K
6
$15K
7
$5K
8
$3K
9
$13
10
–
11
–